Literature DB >> 17234962

Mechanisms of abnormal calcium homeostasis in mutations responsible for catecholaminergic polymorphic ventricular tachycardia.

Vivek Iyer1, Roger J Hajjar, Antonis A Armoundas.   

Abstract

Catecholaminergic polymorphic ventricular tachycardia is a heritable arrhythmia unmasked by exertion or stress and is characterized by triggered activity and sudden cardiac death. In this study, we simulated mutations in 2 genes linked to catecholaminergic polymorphic ventricular tachycardia, the first located in calsequestrin (CSQN2) and the second in the ryanodine receptor (RyR2). The aim of the study was to investigate the mechanistic basis for spontaneous Ca2+ release events that lead to delayed afterdepolarizations in affected patients. Sarcoplasmic reticulum (SR) luminal Ca2+ sensing was incorporated into a model of the human ventricular myocyte, and CSQN2 mutations were modeled by simulating disrupted RyR2 luminal Ca2+ sensing. In voltage-clamp mode, the mutant CSQN2 model recapitulated the smaller calcium transients, smaller time to peak calcium transient, and accelerated recovery from inactivation seen in experiments. In current clamp mode, in the presence of beta stimulation, we observed delayed afterdepolarizations, suggesting that accelerated recovery of RyR2 induced by impaired luminal Ca2+ sensing underlies the triggered activity observed in mutant CSQN2-expressing myocytes. In current-clamp mode, in a model of mutant RyR2 that is characterized by reduced FKBP12.6 binding to the RyR2 on beta stimulation, the impaired coupled gating characteristic of these mutations was modeled by reducing cooperativity of RyR2 activation. In current-clamp mode, the mutant RyR2 model exhibited increased diastolic RyR2 open probability that resulted in formation of delayed afterdepolarizations. In conclusion, these minimal order models of mutant CSQN2 and RyR2 provide plausible mechanisms by which defects in RyR2 gating may lead to the cellular triggers for arrhythmia, with implications for the development of targeted therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17234962     DOI: 10.1161/01.RES.0000258468.31815.42

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  13 in total

1.  Local control of β-adrenergic stimulation: Effects on ventricular myocyte electrophysiology and Ca(2+)-transient.

Authors:  Jordi Heijman; Paul G A Volders; Ronald L Westra; Yoram Rudy
Journal:  J Mol Cell Cardiol       Date:  2011-02-21       Impact factor: 5.000

2.  Ca²⁺-induced delayed afterdepolarizations are triggered by dyadic subspace Ca2²⁺ affirming that increasing SERCA reduces aftercontractions.

Authors:  Martin Fink; Penelope J Noble; Denis Noble
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-10       Impact factor: 4.733

3.  Mitochondrial oxidative stress during cardiac lipid overload causes intracellular calcium leak and arrhythmia.

Authors:  Leroy C Joseph; Prakash Subramanyam; Christopher Radlicz; Chad M Trent; Vivek Iyer; Henry M Colecraft; John P Morrow
Journal:  Heart Rhythm       Date:  2016-05-03       Impact factor: 6.343

4.  Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells.

Authors:  Feng Lan; Andrew S Lee; Ping Liang; Veronica Sanchez-Freire; Patricia K Nguyen; Li Wang; Leng Han; Michelle Yen; Yongming Wang; Ning Sun; Oscar J Abilez; Shijun Hu; Antje D Ebert; Enrique G Navarrete; Chelsey S Simmons; Matthew Wheeler; Beth Pruitt; Richard Lewis; Yoshinori Yamaguchi; Euan A Ashley; Donald M Bers; Robert C Robbins; Michael T Longaker; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2013-01-03       Impact factor: 24.633

Review 5.  Calsequestrin 2 and arrhythmias.

Authors:  Michela Faggioni; Björn C Knollmann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-23       Impact factor: 4.733

Review 6.  Ryanodine receptor-mediated arrhythmias and sudden cardiac death.

Authors:  Lynda M Blayney; F Anthony Lai
Journal:  Pharmacol Ther       Date:  2009-04-01       Impact factor: 12.310

Review 7.  Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease.

Authors:  Emilio G Quetglas; Zlatan Mujagic; Simone Wigge; Daniel Keszthelyi; Sebastian Wachten; Ad Masclee; Walter Reinisch
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

8.  Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.

Authors:  Lei Song; Ronny Alcalai; Michael Arad; Cordula M Wolf; Okan Toka; David A Conner; Charles I Berul; Michael Eldar; Christine E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

9.  Gene therapy for the treatment of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Roger J Hajjar; Alexander R Lyon
Journal:  Circulation       Date:  2014-06-02       Impact factor: 29.690

10.  R4496C RyR2 mutation impairs atrial and ventricular contractility.

Authors:  Cecilia Ferrantini; Raffaele Coppini; Beatrice Scellini; Claudia Ferrara; Josè Manuel Pioner; Luca Mazzoni; Silvia Priori; Elisabetta Cerbai; Chiara Tesi; Corrado Poggesi
Journal:  J Gen Physiol       Date:  2015-12-14       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.